Pesquisa de referências

How the bio revolution could transform the competitive landscape

Recurso electrónico / Electronic resource
Registro MARC
Tag12Valor
LDR  00000cam a22000004b 4500
001  MAP20200016199
003  MAP
005  20230321114200.0
008  180511e20200501usa|||| ||| ||eng d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎922.113
1102 ‎$0‎MAPA20200011316‎$a‎Chui, Michael
24510‎$a‎How the bio revolution could transform the competitive landscape‎$c‎Michael Chui, Matthias Evers, Alice Zheng
260  ‎$a‎New York‎$b‎McKinsey & Company‎$c‎2020
300  ‎$a‎10 p.
520  ‎$a‎Fueled by breakthroughs in biological science and the confluence of exponential advances in data, analytics, and digitization, what until recently might have read like a page out of a science fiction novel is becoming a reality. Moreover, biological innovations have been deployed to aid in the response to COVID-19, allowing for faster identification of the virus, more effective diagnostics, and new bioengineered treatments.1 The wide-ranging implications for business executives should go well beyond the obvious and expected.
650 4‎$0‎MAPA20200005599‎$a‎COVID-19
650 4‎$0‎MAPA20200005391‎$a‎Coronavirus
650 4‎$0‎MAPA20080552022‎$a‎Pandemias
650 4‎$0‎MAPA20080564872‎$a‎Biotecnología
650 4‎$0‎MAPA20080568641‎$a‎Digitalización
650 4‎$0‎MAPA20080557355‎$a‎Biomedicina
650 4‎$0‎MAPA20080557348‎$a‎Biomecánica
650 4‎$0‎MAPA20170006503‎$a‎Transformación digital
7001 ‎$0‎MAPA20200011323‎$a‎Evers, Matthias
7001 ‎$0‎MAPA20200011330‎$a‎Zheng, Alice
7102 ‎$0‎MAPA20080442569‎$a‎McKinsey & Company